Personal Health

How a Texas program funnels millions to anti-abortion groups with little accountability

ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

Year after year, while Roe v. Wade was the law of the land, Texas legislators passed measures limiting access to abortion — who could have one, how and where. And with the same cadence, they added millions of dollars to a program designed to discourage people from terminating pregnancies.

Their budget infusions for the Alternatives to Abortion program grew with almost every legislative session — first gradually, then dramatically — from $5 million starting in 2005 to $140 million after the U.S. Supreme Court overturned the right to an abortion.

Now that abortion is largely illegal in Texas, lawmakers say they have shifted the purpose of the program, and its millions of dollars, to supporting families affected by the state’s ban.

In the words of Rep. Jeff Leach, a Republican from Plano, the goal is to “provide the full support and resources of the state government … to come alongside of these thousands of women and their families who might find themselves with unexpected, unplanned pregnancies.”

But an investigation by ProPublica and CBS News found that the system that funnels a growing pot of state money to anti-abortion nonprofits has few safeguards and is riddled with waste.

Officials with the Health and Human Services Commission, which oversees the program, don’t know the specifics of how tens of millions of taxpayer dollars are being spent or whether that money is addressing families’ needs.

In some cases, taxpayers are paying these groups to distribute goods they obtained for free, allowing anti-abortion centers — which are often called “crisis pregnancy centers” and may be set up to look like clinics that perform abortions — to bill $14 to hand out a couple of donated diapers.

Distributing a single pamphlet can net the same $14 fee. The state has paid the charities millions to distribute such “educational materials” about topics including parenting and adoption; it can’t say exactly how many millions because it doesn’t collect data on the goods it’s paying for. State officials declined to provide examples of the materials by publication time, and reporters who visited pregnancy centers were turned away.

For years, Texas officials have failed to ensure spending is proper or productive.

They didn’t conduct an audit of the program in the wake of revelations in 2021 that a subcontractor had used taxpayer funds to operate a smoke shop and to buy land for hemp production.

They ramped up funding to the program in 2022 even after some contractors failed to meet their few targets for success.

After a legislative mandate passed in 2023, lawmakers ordered the commission to set up a system to measure the performance and impact of the program.

One year later, Health and Human Services says it’s “working to implement the provisions of the law.” Agency spokespeople answered some questions but declined interview requests. They said their main contractor, Texas Pregnancy Care Network, was responsible for most program oversight.

The nonprofit network receives the most funding of the program’s four contractors and oversees dozens of crisis pregnancy centers, faith-based groups and other charities that serve as subcontractors.

The network’s executive director, Nicole Neeley, said those subcontractors have broad freedom over how they spend revenue from the state. For example, they can save it or use it for building renovations.

Pregnancy Center of the Coastal Bend in Corpus Christi, for instance, built up a $1.6 million surplus from 2020 to 2022. Executive Director Jana Pinson said two years ago that she plans to use state funds to build a new facility. She did not respond to requests for comment. A ProPublica reporter visited the waterfront plot where that facility was planned and found an empty lot.

Because subcontractors are paid set fees for their services, Neeley said, “what they do with the dollars in their bank accounts is not connected” to the Thriving Texas Families program. “It is no longer taxpayer money.”

The state said those funds are, in fact, taxpayer money. “HHSC takes stewardship of taxpayer dollars, appropriated by the Legislature, very seriously by ensuring they are used for their intended purpose,” a spokesperson said.

None of that has caused lawmakers to stop the cash from flowing. In fact, last year they blocked requirements to ensure certain services were evidence-based.

Leach, one of the program’s most ardent supporters, said in an interview with ProPublica and CBS News that he would seek accountability “if taxpayer dollars aren’t being spent appropriately.” But he remained confident about the program, saying the state would keep investing in it. In fact, he said, “We’re going to double down.”

What’s more, lawmakers around the country are considering programs modeled on Alternatives to Abortion.

Last year, Tennessee lawmakers directed $20 million to fund crisis pregnancy centers and similar nonprofits. And Florida enacted a 6-week abortion ban while including in the same bill a $25 million allocation to support crisis pregnancy centers. John McNamara, a longtime leader of Texas Pregnancy Care Network, has been working to start similar networks in Kansas, Oklahoma and Iowa. He’s also reserved the name Louisiana Pregnancy Care Network.

And U.S. House Republicans are advocating for allowing federal dollars from the Temporary Assistance for Needy Families program — intended to help low-income families — to flow to pregnancy centers. In January, the House passed the legislation, and it is pending in the Senate. Rep. Elise Stefanik, R-N.Y., castigated Democrats for voting against the bill.

“That’s taking away diapers, that’s taking away resources from families who are in need,” she said in an interview with CBS News after the vote.

But, as Texas shows, more funding doesn’t necessarily pay for more diapers, formula or other support for families.

Lawmakers rebranded Alternatives to Abortion as Thriving Texas Families in 2023. The program is supposed to promote pregnancies, encourage family formation and increase economic self-sufficiency.

The state pays four contractors to run the program. The largest, which gets about 80% of the state funding, is the anti-abortion group Texas Pregnancy Care Network.

Human Coalition, which gets about 16% of the state funding, said it uses the money to provide clients with material goods, counseling, referrals to government assistance and education. Austin LifeCare, which gets about 3% of the state funding, could not be reached for comment about this story. Longview Wellness Center in East Texas, which receives less than 1% of the funds, said the state routinely audits its expenses to ensure it’s operating within guidelines.

Texas Pregnancy Care Network manages dozens of subcontractors that provide counseling and parenting classes and that distribute material aid such as diapers and formula. Parents must take a class or undergo counseling before they can get those goods.

The state can be charged $14 each time one of these subcontractors distributes items from one of several categories, including food, clothing and educational materials. That means the distribution of a couple of educational pamphlets could net the same $14 fee as a much pricier pack of diapers.

A single visit by a client to a subcontractor can result in multiple charges stacking up. Centers are eligible to collect the fees regardless of how many items are distributed or how much they are worth. One April morning, a client at McAllen Pregnancy Center, near the Texas-Mexico border, received a bag with some diapers, a baby outfit, a baby blanket, a pack of wipes, a baby brush, a snack and two pamphlets. It was not clear how much the center invoiced for these items.

McAllen Pregnancy Center and other Texas Pregnancy Care Network subcontractors were paid more than $54 million from 2021 to 2023 for distributing these items, according to records.

How much of that was for handing out pamphlets? The state said it didn’t know; it doesn’t collect data on the quantities or types of items provided to clients or whether they are essential items like diapers or just pamphlets, making it impossible for the public to know how tax dollars were spent.

Neeley said in an email that educational materials like pamphlets only accounted for 12% of the money reimbursed in this category last year, or roughly $2.4 million out of $20 million. She did not respond to questions from ProPublica and CBS News about evidence that would corroborate that number.

The way subcontractors are paid, and what they’re allowed to do with that money, raised questions among charity experts consulted for this investigation.

In the nonprofit sector, using a fee-for-service payment model for material assistance is highly unusual, said Vincent Francisco, a professor at the University of Kansas who has worked as a nonprofit administrator, evaluator and consultant over the past three decades. It “can run fast and loose if you’re not careful,” he said.

Even if nonprofits distribute items they got for free or close to it, the state will still reimburse them. Take Viola’s House, a pregnancy center and maternity home in Dallas. Records show that it pays a nearby diaper bank an administrative fee of $1,590 for about 120,000 diapers annually — just over a penny apiece. Viola’s House can then bill the state $14 for distributing a pack of diapers that cost the center just over a quarter.

But before they can get those diapers, parents must take a class. The center can also bill the state $30 for each hour of class a client attends.

Rep. Donna Howard, a Democrat from Austin, said the program could be more efficient if the state funded the diaper banks directly. Last year, she proposed diverting 2% of Thriving Texas Families’ funding directly to diaper banks, but the proposal failed.

Records show that in fiscal year 2023, Viola’s House received more than $1 million from the state in reimbursements for material support and educational items plus another $1.7 million for classes. Executive Director Thana Hickman-Simmons said Viola’s House relies on funding from an array of sources and that just a small fraction of the diapers it distributes come from the diaper bank. She said the state money “could never cover everything that we do.”

In some cases, reimbursements have created a hefty cushion in the budgets of subcontractors. The state doesn’t require them to spend the taxpayer funds they get on needy families, and Texas Pregnancy Care Network said subcontractors can spend the money as they see fit, as long as they follow Internal Revenue Service rules for nonprofits.

McAllen Pregnancy Center received $3.5 million in taxpayer money from Texas Pregnancy Care Network over three years, but it spent less than $1 million on program services, according to annual returns it filed with the IRS. Meanwhile, $2.1 million was added to the group’s assets, mostly in cash. Its executive director, Angie Arviso, asked a reporter who visited in person to submit questions in writing, but she never responded.

“This is a policy choice Texas has made,” said Samuel Brunson, associate dean for faculty research and development at the Loyola University Chicago School of Law, who researches and writes about the federal income tax and nonprofit organizations. “It has chosen to redistribute money from taxpayers to the reserve funds of private nonprofit organizations.”

Tax experts say that’s problematic. “Why would you give money to a recipient that is not spending it?” said Ge Bai, a professor of accounting and health policy at Johns Hopkins University.

The tax experts disagree with Texas Pregnancy Care Network’s argument that the money is no longer taxpayer dollars after its subcontractors are paid.

“It’s still the government buying something,” said Jason Coupet, associate professor of public management and policy at Georgia State University, who has studied efficiency in the public and nonprofit sectors. “If I were in the auditor’s office, that’s where I would start having questions.”

State legislators and regulators haven’t installed oversight protections in the program.

Three years ago, The Texas Tribune spotlighted the state’s refusal to track outcomes or seek insight into how subcontractors have spent taxpayer money.

Months later, Texas Pregnancy Care Network cut off funding to one of its biggest subcontractors after a San Antonio news outlet alleged the nonprofit had misspent money from the state.

KSAT-TV reported that the nonprofit, A New Life for a New Generation, had used Alternatives to Abortion funds for vacations and a motorcycle, and to fund a smoke shop business owned by the center’s president and CEO, Marquica Reed. It also spent $25,000 on land that was later registered by a member of Reed’s family to produce industrial hemp.

In an interview with ProPublica, a former case manager recalled how Reed would get angry if employees forgot to bill the state for a service provided to a client.

The former case manager, Bridgett Warren Campbell, said employees would buy diapers from the local Sam’s Club store, then take apart the packages. “We’d take the diapers out and give parents two to three diapers at a time, then she would bill TPCN,” said Campbell.

Reed declined to comment to a ProPublica reporter or to answer follow-up questions via email or text. Neeley, the Texas Pregnancy Care Network’s executive director, said the pregnancy center was removed from the program because its nonprofit status was in jeopardy, not because it had used money on personal spending. She said the network wasn’t responsible for monitoring how A New Life for a New Generation spent its dollars: “The power to investigate these matters of how nonprofits manage their own funds is reserved statutorily to the Texas Attorney General and the IRS.”

The Texas attorney general’s office would not say whether it has investigated the organization. Records show that after KSAT’s story, state officials referred the case to an inspector general and that the Texas Pregnancy Care Network submitted a report detailing how it monitored the subcontractor.

The state requires contractors to submit independent financial audits if they receive at least $750,000 in state money; Texas Pregnancy Care Network meets this threshold. However, its dozens of subcontractors don’t have to submit these audits — something experts in nonprofit practices said should be required. In the fiscal year before the alleged misspending came to light, A New Life for a New Generation received more than $1 million in reimbursements from the state, records show.

When ProPublica and CBS News asked how the Health and Human Services Commission detects fraud or misuse of taxpayer funds, Jennifer Ruffcorn, a commission spokesperson, said the agency “performs oversight through various methods, which may include fiscal, programmatic, and administrative monitoring, enhanced monitoring, desk reviews, financial reconciliations, on-site visits, and training and technical assistance.”

Through a spokesperson, Rob Ries, the deputy executive commissioner who oversees the program at Health and Human Services, declined to be interviewed.

The agency has never thoroughly evaluated the effectiveness of the program’s services in its nearly 20 years of existence.

It is supposed to make sure its contractors are meeting a few benchmarks: how many clients each one serves and how many they have referred to Medicaid and the Nurse-Family Partnership, a program that sends nurses to the homes of low-income first-time mothers and has been proven to reduce maternal deaths. The Nurse-Family Partnership does not receive Alternatives to Abortion funding.

In 2022, the Texas Pregnancy Care Network failed to meet two of three key benchmarks in its contract with the state: It didn’t serve enough clients and it didn’t refer enough of them to the nursing program. The state didn’t withhold or reduce its funding. McNamara disputed the first claim, saying the state changed its methodology for counting clients, and said the other benchmark was difficult to hit because too few clients qualified for the nursing program.

In May 2023, when lawmakers passed the bill rebranding the program, the state also ordered the agency to “identify indicators to measure the performance outcomes,” “require periodic reporting” and hire an outside party to conduct impact evaluations.

The agency declined to share details about its progress on those requirements except to say that it is soliciting for impact evaluation services. Records show the agency has requested bids.

Lawmakers decided last year against enacting requirements that would ensure certain services were evidence-based — proven by research to meet their goals — instead siding with an argument that they would be too onerous for smaller nonprofits.

Texas’ six-week abortion ban took effect in 2021, and more than 16,000 additional babies were born in the state the following year. Academics expect that trend to continue.

But the safety net for parents and babies is paper thin.

Texas has the lowest rate of insured women of reproductive age in the country and ranks above the national average for maternal deaths. It’s last in giving cash assistance to families living beneath the poverty line.

Mothers told reporters they are struggling to scrape together enough diapers and wipes to keep their babies clean. A San Antonio diaper bank has hundreds of families on its waitlist. Outside an Austin food pantry, lines snake around the block.

Howard, the Austin state representative, said ProPublica and CBS News’ findings show that the program needs more oversight. “It is unconscionable that a [Thriving Texas Families] provider would be allowed to keep millions in reserve when there is a tremendous need for more investment in access to health care services,” she said.

48 former medical officials warn a second Trump presidency poses major 'threat to public health'

A group of former medical officials is warning Americans of the dangers of a second Donald Trump presidency, arguing in a statement Thursday that the former president poses a major “threat to public health.”

"If he is elected president, Donald Trump will make our fears a reality,” the group wrote.

As Fox News Digital reports, “the group of 48 individuals is led by Dr. Andrew Gurman, former president of the American Medical Association (AMA), and includes six other former AMA presidents, a former U.S. surgeon general, four former acting surgeons general, a number of other former deputy and assistant surgeons general and former representatives of the American College of Physicians.”

READ MORE: 'Can’t control it': Why 'notorious germophobe' Trump fears jail on a 'psychological level'

In their statement, the former medical officials posit that under Trump, “the price of healthcare for American families … would skyrocket, while millions would lose access to healthcare altogether.”

“While his specific policies are at best ambiguous, his track record and his words make clear the damage he would do,” the group notes.

"We therefore encourage anyone concerned about the price, availability and safety of healthcare to keep Mr. Trump out of the White House," the statement adds.

Speaking with Fox News Digital, Gurman said he signed the letter because “returning Mr. Trump to the Oval Office could have real and negative effects on the health of our country.”

READ MORE: No trial until 2025': Political scientist hedges bet on untested constitutional theory' in GA case

"I am concerned that millions might lose access to health care altogether, and that for the rest it might well become much more expensive,” Gurman added.

In the statement, the former medical officials insist “a vote for Donald Trump is a vote for more expensive, more dangerous and less accessible healthcare.”

"A second Trump presidency would mean the American people would risk getting sicker, going broke, both or worse with soaring prescription drug costs, the elimination of protections for patients with preexisting conditions and wins for Big Pharma at the expense of working families," Gurman said.

Read the full statement here, via National Security Leaders for America.

READ MORE: 'Stop lying!' Joe Scarborough excoriates 'hypocrite' Lindsey Graham, GOP over foreign aid

Kari Lake urges AZ governor to end abortion ban she was once 'incredibly thrilled' to support

Arizona Republican U.S. Senate candidate Kari Lake, who spent years promoting Donald Trump’s “Big Lie” that the 2020 election was stolen then lost her 2022 run for governor yet has claimed she is the current “lawful” governor is now calling on the actual governor to come up with a “solution” after the state Supreme Court on Tuesday ruled an 1864 near-total ban on abortion which Lake has called “great” is still legal and enforceable.

“I oppose today’s ruling, and I am calling on Katie Hobbs and the State Legislature to come up with an immediate common sense solution that Arizonans can support,” Lake, who opposes abortion, announced Tuesday.

Just two years ago before losing her race to become Arizona governor, Lake said, “I don’t believe in abortion. I think the older [1864] law is going to take and is going to go into effect that’s what I believe will happen.”

The 1864 law bans nearly all abortion, including in instances of rape and incest, and allows it only to save the life of the mother.

READ MORE: ‘Incoherent’ and ‘Scared’: Trump Slammed Over Latest Abortion Statement

“I believe life begins at conception,” she continued, and when asked about medical abortion, said, “I don’t think abortion pills should be legal.”

That same year she declared, “I’m incredibly thrilled that we are going to have a great law that’s already on the books, so it will prohibit abortion in Arizona.”

The 160-year old law banning abortion was enacted before Arizona became a state. As political scientist David Darmofal noted, “part of Arizona was in the Confederacy just two years before the abortion ban that’s now the law of the state.”

READ MORE: DNC Slams Alleged RFK Jr. Campaign Plan to Leverage Kennedy Name So Congress Can ‘Pick Trump’

Tuesday afternoon, Lake served up a very different statement, declaring, “it is abundantly clear that the pre-statehood law is out of step with Arizonans.”

“I wholeheartedly agree with President Trump – this is a very personal issue that should be determined by each individual state and her people. I oppose today’s ruling, and I am calling on Katie Hobbs and the State Legislature to come up with an immediate common sense solution that Arizonans can support.”

Lake also said she supports protecting in-vitro fertilization (IVF), which legal experts say is incongruent with those who claim to oppose abortion.

Promising to “fight like hell to protect abortion rights once and for all,” U.S. Rep. Ruben Gallego, the Democratic Congressman running for the same Senate seat as Lake, blasted Tuesday’s court ruling and his Republican opponent.

“Today’s ruling is devastating for Arizona women and their families. This is not what Arizonans want, and women could die because of it. Yet again, extremist politicians like Kari Lake are forcing themselves into doctors’ offices and ripping away the right for women to make their own healthcare decisions. Lake called this a ‘great law’ – even though it will ban nearly all abortions, including in cases of rape or incest<‘ Gallego said in a statement. “Our fight against extremist bans like the one enacted today has never been more important — which is why I’m committed to doing whatever it takes to protect abortion rights at the federal level. This isn’t about partisanship — it’s about protecting Arizonans’ rights.”

Watch the videos above or at this link.

Thousands of kids in Florida lost Medicaid coverage on Easter — nearly half a million over past year

Nearly half-a-million children in Florida have lost Medicaid coverage over the past year, after the DeSantis administration and Florida Republican lawmakers chose to not extend Medicaid coverage as the COVID pandemic was declared officially over. Florida reportedly is the only state in the nation to not adopt the Biden administration’s strategies to “minimize terminations for procedural reasons.”

Thousands of children on Easter Sunday lost coverage, NBC6 reported.

“Florida has dropped over 1.3 million people, including 460,000 children, from its state Medicaid program since April 1, 2023, after the end of a pandemic-era policy that banned states from removing ineligible participants from the health insurance program for disabled and low-income people,” the Orlando Sentinel reports.

The reasons for Florida dropping 1.3 million from Medicaid are varied, including improvement in economic status, or just “red tape.”

U.S. Secretary of Health and Human Services Xavier Becerra has issued strong criticism of Florida’s actions.

“Children in Florida have ‘without a doubt’ lost coverage due to paperwork snafus,” Secretary Becerra told the Sentinel. “Becerra previously sent a letter to DeSantis and eight other governors expressing concern about the large number of children who had lost coverage due to red tape.”

READ MORE: ‘Anti-Woke Not Especially Lucrative’: Truth Social Lost Millions Last Year New Filing Reveals

“It continues to not just disturb but confound, I think, a lot of folks that some states have chosen not to address the loss of health care by so many children,” Becerra also said. “… Denying that child those services is not just unconscionable, it’s a nightmare for the family.”

In January the Tallahassee Democrat reported, “the Sunshine State, with 2.5 million uninsured, also has one of the nation’s highest shares of residents without health coverage.”

“In turning back a program that could bring health coverage to roughly 1 million Floridians, Gov. Ron DeSantis and Republican supermajorities in the House and Senate also are rejecting about $5.6 billion in federal aid which would come in the first two years of expansion, and about $4.4 billion annually after that.”

Last year HuffPost‘s Jonathan Cohn reported Florida’s uninsured amounts to “about 12% of its population, which is well above the national average of 8.6%. It’s also more than all but four other states,” Cohn added. “Floridians without insurance suffer because when they can’t pay for their medical care, they end up in debt or go without needed treatment or both. The state suffers, too, because it ends up with a sicker, less productive workforce as well as a higher charity care load for its hospitals, clinics and other pieces of the medical safety net. DeSantis could do something about this. He has refused.”

Meanwhile. The Florida Policy Institute reported last month, “Florida is the only state that has not opted to utilize policy flexibilities offered by the U.S. Department of Health and Human Services to reduce the number of children losing coverage due to system error or red tape.”

Florida has its own children’s health care alternative to Medicaid, Florida’s Children’s Health Insurance Program, or KidCare, which “offers free, subsidized and full-pay insurance for kids whose parents make too much money to qualify for Medicaid,” according to the Sentinel.

But coverage differs from Medicaid, as a report from WFLA shows. The DeSantis administration is suing to try to force the Biden administration to drop a federal policy that requires children to be allowed to stay on the state’s plan even if their parents miss payments.

Dropping 1.3 million people in Florida exacerbates an existing health care problem.

Late last month the South Florida Sun Sentinel reported, “More than 1,300 babies a year, about four a day, die in Florida.” That report, the first in a series of three is titled, “Born to die: Florida’s infant mortality crisis.”

“Health experts say the losses of new life will continue unless the state rethinks how it fails mothers before and during pregnancy,” the paper observed. “The biggest risk to an infant’s health is always the mother’s health. When mothers have preexisting conditions, like diabetes, obesity or heart disease, their babies face a higher risk of death. Everything from Florida’s impenetrable insurance structure to its ineffective investment in maternal and prenatal health contributes to the high rate of babies who die within their first year of life, sometimes within their first minutes.”

READ MORE: Biden Should Have Attended Slain NYPD Officer’s Wake ‘For Optics’ Says Tomi Lahren

“Compared to a decade ago, pregnant women in Florida are older, less healthy and have more complications during birth, according to Florida Department of Health maternal health records. They also are living in a state where access to insurance — or the right insurance — is a barrier to primary and prenatal care.”

The Sun Sentinel also offered these statistics:

“Six of every 1,000 babies born in Florida die before their first birthday, a rate that exceeds the national average of 5.6. Florida babies die mostly from birth defects that affect eating or breathing, infections prevalent in preterm and low birthweight babies, and Sudden Infant Death Syndrome. Most infants in Florida who die under the age of 1 die within their very first month. Black babies in Florida die twice as often as white non-Hispanic and Hispanic babies.”

The paper says insurance is a major factor.

“One-fifth of Florida women ages 19 to 44 have no health insurance, which is worse than 46 other states,” while “Florida is one of only 10 states where the Affordable Care Act’s expansion of Medicaid for low-income adults has not been implemented. That means thousands of women of child-bearing age can’t get Medicaid health insurance for primary care who would have coverage in expansion states like Virginia or New York.”

Federal appeals court rules emergency rooms are not required to perform life-saving abortions

"Emergency rooms not required to perform life-saving abortions, federal appeals court rules" was first published by The Texas Tribune, a nonprofit, nonpartisan media organization that informs Texans — and engages with them — about public policy, politics, government and statewide issues.

Sign up for The Brief, The Texas Tribune’s daily newsletter that keeps readers up to speed on the most essential Texas news.

Keep reading...Show less

Senator calls for DOJ action against Philips for keeping CPAP machine complaints secret

ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

Series: With Every Breath:Millions of Breathing Machines. One Dangerous Defect

Philips Respironics received thousands of complaints about a dangerous defect in its breathing machines but kept them secret for years as stock prices soared. The devices, including the popular DreamStation for sleep apnea, went to children, the elderly and veterans before the global giant announced a massive recall.

A powerful U.S. senator is calling on federal prosecutors to take immediate action against Philips Respironics after revelations the global company withheld thousands of warnings about popular breathing machines capable of spewing hazardous particles and fumes into the masks of patients.

“Philips brazenly turned a blind eye to its dangerous defective machines all in the name of profit,” Sen. Richard Blumenthal, D-Conn., said in a statement about the device maker, which has long dominated the market for ventilators and sleep apnea machines.

The call for enforcement from the Department of Justice comes just days after an investigation by ProPublica and the Pittsburgh Post-Gazette revealed the company kept secret more than 3,700 complaints about the faulty devices over the course of 11 years before launching a massive recall in 2021.

At the time, Philips acknowledged that an industrial foam placed inside the devices to reduce noise could break down in heat and humidity and release material into the air paths of the machines. By then, the company’s two factories in Pittsburgh had turned out millions of the tainted devices, which were delivered to infants, the elderly, COVID-19 patients and at least 700,000 veterans.

As the complaints mounted, stock prices for the device maker’s parent company, Royal Philips, soared to the highest levels in at least 40 years. In a statement, Philips said it regrets any “distress and concern” caused by the recall and it is cooperating with prosecutors and regulators.

“Philips’ priority is patient safety and quality,” the company said.

Safety tests on the foam by Philips in the wake of the recall were called into question by the FDA on Thursday, which said in a statement that the tests were not adequate and did not “fully evaluate the risks posed to users.” Philips agreed to conduct additional tests, the agency said.

Stock prices for Royal Philips, which fell in the wake of the ProPublica and Post-Gazette investigation, dropped by more than 9% on Friday morning after the FDA announcement.

The Justice Department, which has been examining the company’s testing practices and safety claims, can impose a range of penalties against medical device companies in violation of federal safety laws, including civil sanctions and criminal charges.

“Philips knew about the serious risks of its breathing machines for years, but inexcusably, withheld critical information,” said Blumenthal, a member of the Senate Judiciary Committee and chair of an investigations subcommittee that probes violations of laws and regulations impacting national health and safety. “The DOJ must take immediate, aggressive action against Philips for its years-long wrongdoing.”

Senate Majority Whip Dick Durbin, D-Ill., also lambasted Philips for “allowing consumers to breathe in harmful particles from their CPAP machines.”

“It’s deeply disturbing that Phillips would sit on this information as Americans became sicker and sicker,” Durbin said in response to the news organizations’ investigation.

To keep the public safe, federal law requires device makers to submit reports of device malfunctions, patient injuries and deaths within 30 days. In the years before the recall, ProPublica and the Post-Gazette found, Philips withheld the vast majority of complaints about the foam from the Food and Drug Administration, which oversees the medical device industry.

News of the recall stunned patients and their doctors, who scrambled to find information about the potential health risks. The FDA has since classified the recall as the most serious, for device defects that can cause severe injury or death.

“All I could do is tell them the truth, what their options were and be sympathetic,” said Dr. Byron Cooper, a Philips CPAP user and newly retired pulmonologist who treated sleep apnea patients in Washington, D.C. “It would have helped to have more transparency.”

Durbin and Rep. Jan Schakowsky, D-Ill., recently proposed legislation to streamline the recall process so that patients quickly learn about potential health risks.

“When these recalls, like the one Phillips finally issued after more than a decade, come to light, consumers have a right to be informed,” Durbin said.

Philips has said that complaints about the foam were limited before the recall and evaluated on a case-by-case basis, and that when it became aware of the potential significance of the problem in early 2021, the company launched the recall shortly after that.

Philips acknowledged the foam could release chemicals or break into particles capable of causing life-threatening injuries.

Since the recall, the company has changed course, saying recent testing on the DreamStation continuous positive airway pressure, or CPAP, machine and similar devices shows that chemical emissions fall within safety thresholds.

ProPublica and the Post-Gazette obtained copies of the results of four tests carried out in 2021 that were solicited by Philips. Three experts who reviewed the results for the news organizations disputed the company’s claim that emissions fall within safety thresholds. The experts also pointed out that the foam tested positive for genotoxicity, the ability of a chemical to cause cells to mutate, which can lead to cancer.

As doctors struggle to assess the long-term health risks, Connecticut Attorney General William Tong said third-party experts should conduct safety tests on the devices.

“There are still people with defective devices who are rightfully scared and frustrated and they deserve better from both Philips and FDA,” said Tong, who last year joined Blumenthal in a letter to federal regulators urging them to take action against the company.

Kushal Kadakia, a public health researcher at Harvard Medical School who has written about the recall, said the FDA should launch an advisory panel to determine whether the devices are safe and should also require Philips to carry out a study tracking the long-term health consequences.

The FDA, which said it does not comment on compliance matters, said that it is “unsatisfied” with the status of the recall and that the agency would continue to ensure that patients receive accurate information.

Last month, Philips reached a settlement in one of several lawsuits against the company, agreeing to pay at least $479 million to reimburse customers and others for the costs of the defective machines.

After ProPublica and the Post-Gazette published their investigation, which drew on previously undisclosed company records, interviews with Philips insiders and leaked test reports, Philips released a statement saying the stories “do not present new facts and we do not agree with the characterizations made in these articles.”

South Carolina’s all-male conservative Supreme Court rules abortion ban is constitutional

South Carolina’s newly all-male conservative Supreme Court reversed its prior ruling on Wednesday, finding the state’s strict six-week abortion ban is constitutional.

“Writing for the new majority, Justice John Kittredge acknowledged that the 2023 law,” which bans abortion at six weeks, the Associated Press reports, “infringes on ‘a woman’s right of privacy and bodily autonomy,’ but said the state legislature reasonably determined this time around that those interests don’t outweigh ‘the interest of the unborn child to live.'”

In January, justices on South Carolina’s Supreme Court had ruled the state’s ban on abortion was unconstitutional because it violated the right to privacy.

POLL: Should Trump be allowed to hold office again?

In February, the court’s only woman justice retired, making South Carolina the only state in the nation with an all-male Supreme Court.

The Associated Press at the time called it “a development that comes amid increasing Republican scrutiny of the court that narrowly struck down the conservative state’s abortion ban last month.”

“The Republican-led Legislature chose Judge Gary Hill to replace the high court’s lone female justice, Kaye Hearn, who had reached the court’s retirement age and who wrote the leading opinion in the 3-2 ruling overturning the state’s 2021 abortion ban,” the AP noted. “Hill was the only candidate for the position remaining after two female candidates, Judges Stephanie McDonald and Aphrodite Konduros, dropped out on Jan. 17, which was the day candidates could begin seeking legislators’ support. Although nominees have previously left such races when they decided they lacked the votes, the departures have not often happened so swiftly.”

READ MORE: 'He's in for quite the ride': John Eastman surrenders at Atlanta jail while facing possible disbarment

In May, South Carolina Republican Governor Henry McMaster signed a new six-week abortion ban into law “without any notice, which had left dozens of people seeking abortions in limbo and created the potential for a legal abortion becoming illegal as a doctor performed it,” NBC News had reported.

A judge had placed a temporary hold on the law, allowing the state’s Supreme Court to review it in June.

Tuberville targeted by retired colonel for 'kneecapping America’s military' over Pentagon abortion policy

U.S. Senator Tommy Tuberville‘s holds on more than 300 military promotions is creating an “unsafe” situation and “undermining” U.S. military readiness, according to the Secretary of Defense, with one retired U.S. Air Force Colonel stepping up to call the Alabama Republican lawmaker a “traitor.”

Sen. Tuberville has been blocking every military promotion requiring Senate confirmation since February, an act that affects not only those officers but their families, and those who would be promoted to fill their role, along with their families. Defense Secretary Lloyd Austin lamented on Monday that the U.S. now faces the “unprecedented” situation of not having Senate-confirmed leaders atop three military service branches: Army, Navy, and Marines.

The Alabama Senator claims his reason for blocking the promotions is a response to the Pentagon’s policy of reimbursing service members who need to travel out of state to obtain abortion services. That policy was put in place after the U.S. Supreme Court struck down Roe v. Wade, and some Republican-led states began enacting abortion bans.

Retired U.S. Air Force Colonel Moe Davis is an outspoken attorney and former administrative law judge known for resigning as the Chief Prosecutor at Guantanamo Bay over his opposition to waterboarded prisoners being charged – waterboarding is considered torture by Davis and many authorities, and is also considered illegal and a possible war crime.

On Monday Col. Davis declared, “Thanks to Tommy ‘Tantrum’ Tuberville, the Army, Navy & Marine Corps do not have confirmed leaders and hundreds of other senior military officers are in limbo. If you think the @GOP gives a rat’s ass about America’s military and nat’l security, you’re a special kind of stupid.”

He also nicknamed Sen. Tiberville “Traitor Tubbs.”

“Because of @SenTuberville, the Army, Navy & Marine Corps lack leaders, so who bankrolls Traitor Tubbs?” he asked. Davis answered his own question, listing companies including Boeing, Lockheed Martin, FedEx, John Deere, TMobile, CSX, and the U.S. Chamber of Commerce, among others.

Davis slammed Lockheed Martin in particular.

“It’s a disgrace that defense contractors and those who love to be seen waving the flag and talking about how they support the troops bankroll the lone senator who is single-handedly kneecapping America’s military. They talk the talk, but they don’t walk the walk,” he wrote.

He widened his attack to include other top military contractors, and included an image of the wall of photos of the Joint Chiefs of Staff, now missing three top leaders.

See Col. Davis’ social media post above or at this link.

Ohio voters reject GOP 'power grab' aimed at thwarting abortion rights amendment

Ohio voters on Tuesday decisively rejected a Republican-authored measure that would have made it more difficult to amend the state constitution through the ballot initiative process, a billionaire-funded effort aimed at preempting a November vote on abortion rights.

If approved by voters, the measure known as Issue 1 would have raised the threshold for passage of a constitutional amendment from a simple majority to 60%. The measure also would have imposed more stringent signature requirements for Ohio ballot initiatives.

The GOP proposal—which was the only item on the ballot in Tuesday's special election—failed by a vote of 43% to 57%, according to the Ohio secretary of state's office.

"Issue 1 was a blatant attempt by its supporters to control both the policy agenda and the process of direct democracy," said Rachael Belz, the CEO of Ohio Citizen Action, one of the groups that mobilized in opposition to the proposal. "When they forced Issue 1 onto the ballot, they awakened a sleeping giant and unleashed a movement. And that movement isn't going away tomorrow. It will continue to build and grow and to carry us through to victories in November and beyond."

The Republican push for Issue 1 drew national attention given the implications for both the democratic process and reproductive rights in Ohio, where abortion is currently legal through 22 weeks of pregnancy—though the state GOP is working to change that.

A proposed constitutional amendment on the ballot in November would codify the right to abortion access in the Ohio constitution, stating that "every individual has a right to make and carry out one's own reproductive decisions, including but not limited to decisions on contraception, fertility treatment, continuing one's own pregnancy, miscarriage care, and abortion."

Frank LaRose, Ohio's Republican secretary of state and a U.S. Senate hopeful, said in June that Issue 1 was " 100% about" preventing passage of the abortion rights amendment.

Recent polling indicates that around 58% of Ohioans back the proposed amendment—a level of support that would have been insufficient had Issue 1 succeeded.

"From defeating Issue 1 tonight to submitting nearly twice the amount of signatures needed to get a measure protecting abortion access on the ballot in November, Ohio voters have made clear that they will settle for nothing less than reproductive freedom for all," Mini Timmaraju, the president of NARAL Pro-Choice America, said in a statement late Tuesday.

"Republicans should be ashamed of their efforts to subvert the will of voters," Timmaraju added. "Seeing this measure defeated is a victory for our fundamental rights and our democracy. We're grateful to our partners on the ground for their tireless efforts to secure abortion rights and access. We look forward to fighting by their side to lock this fundamental freedom into law in November."

The Republican attack on the ballot initiative process in Ohio is part of a nationwide GOP effort to limit direct democracy as the party—emboldened by the right-wing U.S. Supreme Court—continues its effort to roll back abortion rights and other freedoms.

According to a March tally by election analyst Stephen Wolf, Republicans have recently tried to make it harder to pass citizen-led ballot initiatives in at least 10 states, including Ohio, Florida, Arizona, and Arkansas.

"In the many states where the GOP has refused to take action, activists have used ballot initiatives to expand Medicaid, raise the minimum wage, secure abortion rights, protect the right to vote, curb gerrymandering, legalize marijuana, promote gun safety, and more," Wolf wrote. "How have Republicans reacted to this? By trying to make it harder to pass initiatives in the first place."

Catherine Turcer, executive director of Common Cause Ohio, said Tuesday that "since 1912, Ohioans have had the right to collect signatures and bring proposed constitutional amendments directly to voters."

"This is an important check on the state legislature, hyperpartisan politicians, and special interests who did everything they could to take away that right," Turcer added. "It was the hard work and resilience of Ohioans of all parties that prevented the destruction of a foundational right we've held for 110+ years."

"Tonight's results," Turcer said, "are a resounding victory for Ohio voters who helped stop this power grab by the state legislature and Secretary of State Frank LaRose."

Jamie Raskin nails GOP at Covid hearing: Lab leak 'would only deepen Trump's culpability'

Rep. Jamie Raskin (D-MD) warned Republicans that former President Donald Trump's culpability for Covid-19 deaths "would only deepen" if their theory about a lab leak in China was true.

Raskin made the remarks during a Tuesday House Oversight hearing into the origins of Covid-19.

"We are all interested in finding out the origins of the Covid-19 epidemic to make sure that such a nightmare never happens again to us," Raskin began. "Some people think that the finding that it all started with a lab leak would somehow absolve Donald Trump of his lethally reckless response to the pandemic. Of course, his response was dangerously dysfunctional regardless of how it got started."

The Maryland Democrat pointed out that Trump's former adviser, Dr. Deborah Birx, "said that we lost hundreds of thousands of American lives because of the flaws in the response."

IN OTHER NEWS: Trump has set up an 'embarrassing' trap for his own lawyers: national security attorney

"But even if the virus came from a lab, as indeed it could have, we don't know that yet, that would only deepen Donald Trump's culpability because he was the one who repeatedly and enthusiastically praised China's early handling of the pandemic and assured us that he was working closely with President Xi on the response to it," Raskin added. "So let's just get the facts straight and leave all the political myth-making aside."

Watch the video below or at this link.

How executives and well-connected investors make exquisitely timed trades in health care stocks

ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox

.

Series: The Secret IRS Files

Inside the Tax Records of the .001%

The case was a bold step for the Securities and Exchange Commission.

In 2021, the agency accused Matthew Panuwat of insider trading. Five years earlier, he had learned that his own company, a biopharma operation called Medivation, was about to get acquired. But instead of buying shares in his employer, he bought options in a competitor whose stock could be expected to rise on the news. The agency says he made $107,000 in illicit profits.

For the first and so far only time, the SEC filed a case that accuses an executive of using secret information from his own company to trade in the stock of a rival. “Biopharmaceutical industry insiders frequently have access to material nonpublic information” that impacts both their company and “other companies in the industry,” Gurbir Grewal, the commission’s director of enforcement, warned in announcing the case. “The SEC is committed to detecting and pursuing illegal trading in all forms.”

One of the cornerstones of the agency’s case against Panuwat is that Medivation had a policy that explicitly barred employees from buying or selling competitors’ stock based on company information not available to ordinary investors.

It wasn’t just Panuwat who risked violating Medivation’s policy, a trove of confidential IRS data obtained in recent years by ProPublica shows.

It was also his then-boss, CEO David Hung.

The records show Hung traded frequently in the stock and options of pharmaceutical companies, betting tens of millions of dollars on the rise or fall of shares of dozens of such firms, some of which were direct competitors with his company. Several of his trades came just before news about a rival that he could have learned about in his position as CEO. In one case, he traded ahead of news he personally announced.

The size of Hung’s trades dwarfs those that got his subordinate, who has denied any wrongdoing, in the crosshairs of the SEC.

Hung’s spokesperson acknowledged the CEO has learned nonpublic information about competitors, but denied that information ever informed any of his dozens of trades.

Earlier this year, ProPublica revealed that some executives with access to nonpublic industry informationhad made remarkably well-timed transactions in the securities of their direct competitors and partner companies. Securities law experts said many of the trades, which in some instances rapidly delivered millions of dollars in profit, warranted examination by regulators. The transactions ranged across sectors: from energy to toys, paper products to mortgage servicers.

But one industry stood out for both its frequency and variety of questionable trades: biotech and other relatively small health care enterprises such as medical device makers and drug companies. Dozens of wealthy executives and well-connected investors reported superbly timed stock trades in such companies, including in businesses they competed with or had personal ties to.

ProPublica has analyzed millions of transactions documented in the tax records of the wealthiest taxpayers, including many of the nation’s top business leaders. A high proportion of these trades involved plain vanilla investments, with long-term holdings of blue chip stocks and the like. But a minority of the transactions displayed what experts say are hallmarks of potentially suspicious trading.

Finding well-timed trades was only a starting point for ProPublica’s analysis. We then scrutinized transactions that occurred just before market-moving news, particularly those that represented a departure from an investor’s previous investing pattern, because they either had hardly if ever traded a particular company's stock, were trading an unusually high dollar amount or were making use of risky options for the first time. We examined whether those people had any possible nonpublic means of obtaining information about the companies whose stock rose or fell at an opportune moment. We provided anonymized descriptions of these trades to academics, former prosecutors and former SEC officials, and focused on those they said should have garnered the attention of regulators.

Among the notable examples:

The chairman of a biotech company bought shares in a corporate partner just as the partner was reaching the final stages of secret negotiations to be purchased.

The chairman of a bone health company made aggressive bets on a medical technology firm run by an adviser to his board just before its sales took off, netting him $29 million in a series of options trades.

A wealthy investor with ties to a niche area of cancer research personally traded, for the first time ever, in a company in that sector just before it was taken over. He bought high-risk options that earned him a quick $1 million in profit.

An information edge can be lucrative in any industry, but especially so in the health care sector. Many of its companies are built around only one or a handful of products, making their shares particularly volatile and ripe for profit by investors with inside knowledge. Biotechs and other up-and-comers face clear make-or-break moments: Clinical trials, signals from regulators or takeover rumors can cause wild swings in share prices.

Since beginning to report on our massive trove of IRS records in 2021, ProPublica has analyzed the data and used it as the basis for a series of articles, The Secret IRS Files, that reveal the many ways in which the tax code favors the rich and how the ultrawealthy exploit those advantages.

The IRS data also included millions of records of wealthy taxpayers’ stock and options trades, provided by the brokerages that handled the trades. While the SEC routinely reviews stock trading data from brokers and exchanges, the agency does not have access to IRS data, which in many ways is more comprehensive. (A spokesperson for the SEC declined to comment for this article.)

The securities experts said there is no fixed definition of what makes a trade suspicious and worthy of further investigation. A propitious trade for a relatively small amount, for example, might still warrant scrutiny if the investor has a tie to the company. One excellently timed trade is less noteworthy if the investor frequently trades in that security. A trade with a modest return could still be problematic if it came before news the investor knew about in advance or set in motion. And even if a trader’s investment strategy in a stock wasn’t ultimately successful, a single lucrative trade could still be deemed illegal.

The experts interviewed by ProPublica about the trading patterns examined in this story said that while each should trigger closer scrutiny from regulators, the question of whether they would lead to any action would depend on a host of additional factors. They noted that stock trades are generally deemed to violate insider trading laws only when multiple elements are met. The trader must have had information, not yet publicly known, that would affect the company’s share price. And the trader, or the person who provided the tip, must have had a duty not to disclose the information or use it for personal benefit.

ProPublica’s records give no indication as to why investors made particular trades or what information they possessed. The wealthy investors named in this story either denied their trades were improper or did not comment.

The personal trading policy for Medivation, the multibillion-dollar company Hung ran, was particularly explicit. It warned its employees to be careful trading the shares of competitors because Medivation’s employees possess nonpublic information that can affect those companies’ stock prices as well. “For anyone to use such information to gain personal benefit,” the policy stated, “is illegal.”

But ProPublica’s data show Hung, who has led a number of biopharma companies and has been described in the press as a master dealmaker, risked violating the company’s policy by trading in the securities of competitors. During the decade-plus in which Hung led Medivation, most of his proceeds from securities transactions in companies other than his own involved the pharma sector.

With timely trading, he sometimes scored gains of hundreds of thousands of dollars or managed to avoid a calamitous loss. (The records show that he sometimes lost money as well.)

Securities experts with whom we described his trading patterns and high-ranking role (but not his name) said the investments appeared to show a top executive capitalizing on information not available to the average investor.

In July and August 2011, Hung’s tax records show, he sold more than a million dollars’ worth of stock in a company called Dendreon. Dendreon was then producing a promising prostate cancer therapy that Hung’s firm was competing against, working to get their own drug to market. The day after Hung sold the last of his two roughly half-million-dollar tranches of Dendreon stock in August, the company’s share price fell 67% because of poor sales and a lack of initial enthusiasm from doctors about its prostate cancer drug.

Industry experts said that when a pharmaceutical is in late-stage development, as Medivation’s drug was at the time, the company will normally have its representatives examine the competitive landscape, including surveying doctors’ offices about rival drugs. And business-side employees of companies, even competitors, frequently mingle and trade gossip at conferences.

A few months later, in October 2011, Hung again bought shares of Dendreon, but quickly made a U-turn days after, selling those shares off for about $150,000, essentially the same price he had bought them for. A week later, Hung announced that his company had learned that trials had gone so well for its own prostate cancer therapy that the drug was going to start being offered even to participants who had been given a placebo. “These results are both an important step toward making this life-extending potential treatment available to the prostate cancer community and a significant milestone for our company,” Hung said in a press release at the time.

Just as Hung announced his company’s promising results, Dendreon released lackluster quarterly earnings. Its stock fell 37%.

David Nierengarten, an analyst who covered both companies at the time, told ProPublica the earnings report caused most of the fall, but part of it could also be attributed to Medivation’s clinical trial results, which posed a threat to Dendreon’s market share. Hung’s spokesperson said that Hung did not know the outcome of his company’s clinical trials when he sold Dendreon’s shares.

Hung sold Dendreon shares on almost two dozen occasions over six years, with most of the trades for less than $150,000. Hung’s spokesperson denied he had any relevant nonpublic information when he made his Dendreon trades.

In one instance, tax records show Hung traded a competitor’s stock ahead of news he himself disclosed that experts said would likely qualify as material.

On Aug. 24, 2015, Hung announced that Medivation was acquiring a cancer-fighting medication from a company called BioMarin. The drug was one of a handful of cutting-edge new drugs that Hung hailed as an “exciting class of oncology therapeutics.”

What Hung didn’t say was that on the same day his company finalized the acquisition — but three days before the public announcement — he made a purchase in his personal stock trading account. He bought about $8 million in shares of Clovis Oncology, a company that was separately developing a drug in the same treatment category, known as “PARP inhibitors.”

After the acquisition, the pharmaceutical trade press noted that there was growing interest in this class of drugs. Hung’s deal marked the first big acquisition of a PARP inhibitor.

“Obviously all the PARPs are going to pop,” said Nierengarten, the analyst who covered Hung’s company. Clovis is a small company reliant on a small number of drugs, “so it’s really going to pop,” he said.

And it did. In the week after the Medivation agreement was announced, Hung’s stock purchase paid off: The price of Clovis shares increased by about 11%, a rise experts attributed partly to Hung’s drug acquisition.

By the time Hung sold the shares the next month, he netted $1.25 million in profit.

Hung’s spokesperson defended the trades, saying Hung did not believe Medivation’s acquisition of BioMarin’s drug would affect the share price of a company that made a drug in the same class.He also said most of the stock’s rise came in the days after the news of the acquisition, not the day of, which he said indicated Hung’s profit was attributable to other factors.

The Clovis shares that Hung bought represented the final step in what records show was a series of complex transactions involving what are known as stock options — arrangements to buy or sell a security at some future date. In April 2015, Hung started selling Clovis “put options.” That meant he was entering into a contract that gave another investor the right to sell Clovis shares to him in the near future at a specified price. It was essentially a bet by Hung that Clovis shares would remain at roughly the same price or rise (a sophisticated and unusual transaction for a typical retail investor).

In April and May, Hung sold a small number of his contracts. In June and July, he began selling more frequently and in larger quantities: 17 times as many contracts as he had sold in the previous two months. According to his spokesperson, this was around the time Hung was approached to buy BioMarin’s drug.

The expiration dates for the options were staggered. A large group of his contracts expired on the same day he finalized the drug acquisition.

At that moment, Hung had two choices, both seemingly unpleasant. According to his spokesperson, he likely could have paid cash to end the contracts, which would have resulted in an immediate loss since the options were for a higher stock price than Clovis was trading at on that day. The contracts also allowed him to buy the specified number of shares, a seemingly bad deal since he would pay anywhere from $75 to $85 per share for stock that was trading at less than $73.

But on that day, Hung knew something the market didn’t: that his company was about to announce it was buying Biomarin’s drug.

Hung bought about $8 million worth of Clovis shares. After his company’s announcement, Hung was in the black in a matter of days, even after he bought at the inflated price. The option trades had worked out beautifully. He sold the shares the next month, turning that $1.25 million profit.

Hung’s spokesperson pointed out that, taking into account all of the Clovis options he sold that year, Hung actually lost about $100,000. The time horizon for some of the contracts was much longer, with expiration dates into the following year. Hung, he said, held on to some of his contracts and ultimately lost money when the price of Clovis shares declined significantly a few months later. The spokesperson also said that someone trying to capitalize on nonpublic information could do so more efficiently by buying shares in a company rather than through a complicated series of options trades.

ProPublica described Hung’s options dealing in Clovis, without revealing his identity, to Dan Taylor, a professor at the Wharton School and a leading insider-trading expert. “The trades in question seem at best highly unethical and at worst they may be illegal,” Taylor said. “I would caution any and all executives from engaging in the behavior described here. There's significant legal jeopardy if that behavior was brought to the attention of regulators.”

Harry Sloan did not make his name in the health care industry. He came to prominence in Hollywood.

But in 2017 Sloan made a sizable bet on Juno Therapeutics, a Seattle-based biopharma company focused on cancer treatments.

Sloan had never personally invested in Juno before. There’s also no sign in his tax records, which span the years 1999 to 2019, that he purchased options to invest in other companies.

But on Dec. 14 and 15, 2017, he did both for the first time in ProPublica’s tax data. He bought more than a quarter-million dollars of Juno call options, a contract giving him the right to buy the stock at a specific price. The options were “out of the money,” meaning the price was well over what the stock was trading at at the time. The bet would pay off only if Juno stock jumped significantly.

Options, especially out-of-the-money options like the ones Sloan bought, are risky but can carry huge rewards. You can win big if the stock price rises above the purchase price set by the contract. If Amazon stock sells for $125 a share, an option to buy a share at $130 is worthless at the expiration date unless the market price jumps above $130. If Amazon stays at $125, you’ve spent money for nothing. But if it soars to $175 a share, you stand to make a lot from a small investment.

Sloan’s timing proved prescient. The public didn’t know it yet, but December 2017 was a hugely significant moment in Juno’s history. The company had been privately negotiating to sell itself to Celgene, a leader in the field of cancer treatments. On the same days that Sloan bought his options, Celgene significantly raised its offer and Juno agreed to be taken over.

When The Wall Street Journal broke the news of the imminent acquisition a month later, Juno’s share price skyrocketed from $46 a share to $69, its largest one-day increase ever, and Sloan quickly cashed in. He sold much of his first tranche of options for $677,000. In two decades of records, it was the largest sale he’d made in a security of a company where he hadn’t been an insider.

In all, he claimed more than $1.1 million in profit from his Juno trades, a 450% return on the cost of his options.

Of the 251 trading days in 2017, there were only a dozen other days where Sloan could have purchased options and seen the stock’s price increase as much as it ultimately did over the short period he held the bulk of his position.

Through a spokesperson, Sloan, who has been a prominent fundraiser for presidential candidates on both sides of the aisle, declined to answer questions from ProPublica, instead providing a brief statement: “Any insinuation of unethical or improper activity here is false, and contrary to the reputation Mr. Sloan has developed over the course of his lifetime.”

ProPublica provided an anonymized description of Sloan’s trades to a former SEC commissioner, two former SEC attorneys and two leading insider trading academics. All five said this sort of fact pattern could draw scrutiny from regulators because of how well-timed the trades were, and how anomalous compared to Sloan’s trades before and after.

"If you see out-of-the-money call options, no prior history of trading in that name, excellent timing and a large profit, generally yes, I would expect that to draw attention from regulators," former SEC Commissioner Allison Herren Lee said.

A remarkably timed trade may be even more suspicious, she said, if a trader had some sort of personal tie to the niche industry the company is in.

Though much of his career was in Hollywood — Sloan had been an entertainment lawyer and eventually became CEO of Metro-Goldwyn-Mayer — he is not without his connections to biotech and the subsector Juno was in. Sloan knew Arie Belldegrun, one of the leaders in the field of “CAR T-cell” therapy, a novel cancer treatment in which human cells are modified to attack cancer cells. It is the same niche that Juno specialized in. Sloan and Belldegrun were both active in art philanthropy, backing the same Los Angeles art museum at least as far back as 2013; Belldegrun’s wife co-hosted a VIP screening in 2011 for a movie produced by Sloan’s wife. And Sloan donated $3.2 million to Belldegrun’s lab at UCLA in 2017.

Belldegrun was previously CEO of Kite Pharma, a Juno competitor, before selling his company just months before Juno was acquired. Around the time that Sloan was investing in Juno call options, Belldegrun was starting a new CAR-T company. (Four years later, in 2021, Sloan helped take public a biological engineering firm called Ginkgo Bioworks. One of his partners in that venture was Belldegrun.)

There is no evidence that Sloan and Belldegrun ever discussed Juno. Belldegrun did not respond to repeated requests for comment.

Robert Stiller made his fortune off smoking paraphernalia and coffee. He helped launch E-Z Wider, rolling papers used for joints and cigarettes, before founding Green Mountain Coffee Roasters, the multibillion-dollar company that helped popularize K-Cup coffee pods. That role propelled him to business celebrity, as Forbes declared him “entrepreneur of the year” in 2001.

After Stiller left Green Mountain, he served as chairman of the board of AgNovos, a bone health startup. There, the board Stiller led hired a special adviser: Stephen MacMillan, an experienced medical technologies executive. By the end of 2013, MacMillan was named CEO of Hologic, another medical technology company, but he stayed on at AgNovos as a special adviser to Stiller.

Within a few months, Stiller began investing in Hologic for the first time — and aggressively.

On 33 days between March 2014 and January 2015, he bought a total of $9.8 million in call options in MacMillan’s company. Each was a win, netting him a combined $29 million in profit, almost a 300% return. Stiller’s tax records show no indication that he purchased options in companies other than Hologic and Green Mountain from 1999 to 2019.

The rise in Hologic’s share price was driven largely by revenue growth from its innovative line of mammogram devices, which are more effective than standard breast scans because they provide a three-dimensional view that helps reveal smaller tumors before they’ve grown. The company began reporting particularly strong growth from that product line in late April 2014, after Stiller’s first purchases. The excitement around the product grew from there, as the line continued to beat Wall Street’s revenue expectations and more studies affirmed its effectiveness. The company would have noticed orders picking up months before revenue numbers were announced, according to an industry expert who asked not to be named to avoid antagonizing industry contacts.

Stiller began buying call options in early March.

Reached by phone, Stiller said he invested in Hologic because he had confidence in MacMillan, but said MacMillan never shared detailed information about the company’s inner workings with him. “I would ask him, ‘How are things going?’ and he’d say, ‘Good,’” Stiller said. (MacMillan did not respond to requests for comment.)

Stiller said he thought he had purchased options in other companies during that period as well, but couldn’t name examples. He said he might have also bought shares of Hologic in addition to options, though he didn’t know when.

He acknowledged that buying call options in a company run by someone he knew, before it announced good news, “might not look good” and said that in retrospect he might have refrained. “I always have acted under the highest ethical shit, and I understand insider trading, and I would never do it, and I would never ask anybody else to do it,” Stiller said. “It’s just not in my DNA.”

Even by Stiller’s account of his discussions with MacMillan, his trades risked running afoul of the law. ProPublica described Stiller’s trades, without identifying him, to Chip Loewenson, a longtime white-collar defense attorney who has handled insider trading cases.

“What you described sounds like it could be insider trading,” Loewenson said. “Even if you take his word for it, that all he asked is how it’s going, and he says it’s going well, that could be material nonpublic information.” As Loewenson described it, a one-word answer about how a company is faring could be polite chitchat — or it could carry meaning. “Is that something a reasonable investor would want to know? If you think you're getting an honest answer, yes.”

In 2018, Jim Mullen, a veteran biopharma executive who previously was CEO of biotech powerhouse Biogen and chairman of the Biotechnology Innovation Organization, became chairman of the board of Editas Medicine, a firm based in Cambridge, Massachusetts, that uses gene editing techniques to treat rare diseases. (Mullen stepped down earlier this month after his term ended.) The publicly traded company collaborates with Celgene to use its technology to develop cancer therapies.

Mullen’s tax records show he had unsuccessfully traded in and out of Celgene before in relatively small amounts, but on Dec. 18, 2018, he made his biggest purchase ever of the company’s shares: $73,000 worth, almost as much as all his other past purchases combined.

His timing was excellent.

Celgene was at the time in secret negotiations to be acquired by pharma giant Bristol Myers Squibb. The day before Mullen bought the shares, Celgene had expanded the circle of people who knew about the takeover talks. According to subsequent SEC filings, Celgene informed an unidentified pharma company about the potential acquisition in hopes of soliciting a higher competing bid. The action also raised the risk that the secret talks might leak. (The company that was approached, which would have had to be orders of magnitude bigger than Editas to consider buying Celgene, declined to make a competing offer.)

The next day — the same day Mullen bought shares in Celgene — Celgene’s executive committee decided to move forward with Bristol Myers.

Two weeks after Mullen’s purchase, the deal was announced, sending Celgene’s shares soaring, and ultimately earning Mullen $46,000 in profit and a return of more than 60%.

Mullen and Editas did not respond to requests for comment.

Get in touch

Data background and limitations

'Worst' Trump-appointed judge set to oversee $1.8 billion dollar case that could bankrupt Planned Parenthood

One of the "worst" Trump-appointed judges is set to oversee a case involving a $1.8 billion dollar lawsuit against Planned Parenthood, according to VOX.

In the report, VOX's Ian Millhiser offered a brief overview of Kacsmaryk's history of ruling on abortion-related cases.

"A longtime opponent of abortion, birth control, and homosexuality, Kacsmaryk has handed down decisions attacking the right to birth control and attempting to nullify the federal ban on LGBTQ discrimination by health providers," Millhiser wrote. "His opinion trying to ban mifepristone faulted the FDA for failing to consider a 'study' which found that 77 percent of women who submitted anonymous blog posts to a website called 'Abortion Changes You' reported a 'negative change.'”

READ MORE: 'She knows what she’s doing': Democrat likens Marjorie Taylor Greene attack to 'why Emmett Till was killed'

Millhiser also challenged Kacsmaryk's distortion of the laws.

"Kacsmaryk seems to be uniquely incapable of distinguishing what the law actually says from what he wishes that it says," Millhiser wrote. "And now he will hear an attack on Planned Parenthood that only gets more ridiculous the deeper one digs into the Doe case."

Per the news outlet, "The case, known as Doe v. Planned Parenthood, alleges that Planned Parenthood and its affiliates in Texas and Louisiana engaged in a years-long scheme to defraud those states’ Medicaid systems."

Millhiser went on to explain how the lawsuit's damages were calculated, totaling a staggering $1.8 billion.

"When you add up the money the reproductive health provider allegedly owes, plus the various fines and penalties they could be hit with, Planned Parenthood estimates that they could be ordered to pay as much as $1.8 billion, more than enough to bankrupt Planned Parenthood Federation of America — the national organization that unites Planned Parenthood’s local affiliates — and wipe out its affiliates in Texas and Louisiana," he explained.

READ MORE: 'Embarrassing': Chris Sununu slams GOP and undecided voters' behavior during Trump Town Hall

Millhiser argued that the lawsuit lacks merit as he explained why "no sensible judge" would entertain the case.

"No sensible judge would hold that a litigant can be bankrupted because it acted consistently with a federal court order while that order was in effect," he But this case is being heard by Matthew Kacsmaryk, who’s spent his brief time on the bench acting as a rubber stamp for virtually any conservative litigant who comes to him seeking a court order."

READ MORE: Massachusetts donors have been paying Kyrsten Sinema’s Boston Marathon expenses: report

Florida AG — wife of a DEA agent — accused of 'not standing with the people' as she vows to fight legal pot

Florida Attorney General Ashley Moody, the wife of a Drug Enforcement Administration special agent, is being accused of “not standing with the people” after she vowed last week to fight a proposal to legalize recreational marijuana in the state, Politico reports.

The group Smart & Safe Florida, which is spearheading the ballot initiative to legalize recreational marijuana for adults in the Sunshine State, currently has 786,747 signatures for its ballot question. As the Washington Examiner reports, “to get the ballot question before voters, it will need to receive a number of signatures equal to that of eight percent of the votes cast in the last presidential election, which is equal to more than 885,000 people.”

According to Politico the measure "still needs to get an all-clear from the Florida Supreme Court" in order to go before Florida voters. At least 60 percent of Florida voters would have to vote for legal weed in order to make it law.

READ MORE:GOP tries to keep abortion rights off ballot after major losses: 'Can’t win, so they cheat'

But if Moody has her way, the question of legal weed won’t even make it on the ballot in Florida. Last week, Moody filed an petition with the Florida Supreme Court saying “she would argue that the proposed ballot summary of the amendment is misleading,” Politico reports.

In her letter to the Court, Moody requested an opinion “as to whether the proposed amendment ‘Adult Personal Use of Marijuana’ complies with the single-subject requirement” of the Florida Constitution and “technical requirements in section 101.161(1)” of the Florida Statutes. That statute dictates constitutional amendments “be printed in clear and unambiguous language” and “not exceeding 75 words in length,” among other requirements.

"I believe that the proposed amendment fails to meet the requirements of Section 101.161(1), Fla. Stat., and will present an additional argument through briefing at the appropriate time," Moody said in the letter.

READ MORE:Former Michigan House GOP lawmaker charged in marijuana licensing bribery scheme

In a statement, Smart & Safe Florida said it “respectfully disagrees” with Moody’s challenge.

“We believe the ballot language,” Steve Vancore, a spokesperson for the medical marijuana company Trulieve, told Politico. Trulieve, which is bankrolling Smart & Safe Florida, “[expects] a positive ruling” from the state supreme court, Vancore said.

Critics of the attorney general spoke out against her decision to challenge the language of the initiative.

READ MORE: Key Republican witness may have lied under oath about receiving financial help from Trump ally: report

“Once again our Attorney General is on the wrong side of history, wrong side of this issue and is not standing with the people." Florida Democratic Party chair Nikki Fried, a former Florida agriculture commissioner, told Politico. "Another attack on our democracy."

For Fred Grimm, a Fort Lauderdale journalist, there’s a clear driving force behind Moody’s fight against legal marijuana: 2024.

“Republicans don’t want pot as a running mate to Joe Biden on the Florida ballot,” Grimm wrote last Friday. “Because marijuana can do what Joe Biden can’t — rouse the apathetic wing of the Democratic Party.”

READ MORE:Revealed: Jim Jordan's FBI 'whistleblowers' were paid by Trump ally and spread J6 conspiracy theories

“The GOP’s faux populists know ballot questions like these would have coattails long enough to blow up an election,” he added.

'Stop trampling on women’s rights': Twitter users react to anti-abortion bills’ brutal defeats in red states

In two deep red states, South Carolina and Nebraska, draconian anti-abortion proposals were blocked in state legislatures on Thursday, April 27.

In the GOP-controlled South Carolina State Senate, a bill that would have banned almost all abortions was defeated. And in the Nebraska State Legislature, a vote to end debate on a proposed six-week abortion ban and let the bill proceed failed by a single vote.

Jo Giles, director of the Women's Fund of Nebraska, was pleasantly surprised and was quoted by the Associated Press (AP) as saying, "Wow! This was unexpected, but we're so glad to have this win. We have fought so hard. This bill is not what the majority of women in this state wanted."

READ MORE: Supreme Court stays order banning abortion drug mifepristone

Twitter has been full of reactions, and many users have commented that the bills didn't run into problems in swing states or purple states but in deep red states.

Right-wing firebrand author Ann Coulter is anti-abortion but believes that post-Roe v. Wade, abortion restrictions are going too far and hurting the Republican Party. In response to the news from South Carolina and Nebraska, Coulter tweeted, "Two Republican legislatures failed to pass abortion restrictions this week - South Carolina (near total ban) and Nebraska (6-week ban). Currently, both states allow abortions up to TWENTY-TWO WEEKS. Why not go with a 15-week ban and win???"

John Iadarola of "The Young Turks" described the fate of the South Carolina and Nebraska bills as "a reminder that the GOP's position on reproductive rights is wildly unpopular even in red states."

Twitter user Toni Webb, @GoCubaStudents, "Republicans should stop trampling on women's rights, whether they agree with abortion or not. Republicans guaranteed a Blue Tsunami in 2024 when they blocked ratification of the ERA this week."

READ MORE: Ron DeSantis signs six-week abortion ban into law

@Bennydiego posted, "Abortion bans in deeply conservative Nebraska and South Carolina both fell short of advancing in close legislative votes amid heated debates among Republicans, yet another sign that abortion is becoming a difficult issue for the GOP."

CAP Action tweeted, "This is a major win in the battle against MAGA Republicans’ extreme abortion bans — but the fight continues." And the Global Justice Center posted, "Local resistance against these horrific abortion bans is both inspiring and instructive for all of us fighting for a world that respects our fundamental human right to bodily autonomy. Solidarity to everyone fighting for their communities.

Buzz Machine's Jeff Jarvis, @jeffjarvis, described South Carolina and Nebraska as "political cynicism yields to political pragmatism."

READ MORE: This 'Orwellian' 1870s law could help Republicans enforce a nationwide abortion ban: report

GOP tries to keep abortion rights off ballot after major losses: 'Can’t win, so they cheat'

Last year, after the U.S. Supreme Court ended the federal right to abortion, voters in Kansas, California, Michigan, Vermont, Kentucky, and Montana used the ballot initiative process to show their support for reproductive freedom, both by defeating GOP-backed anti-abortion measures and approving constitutional amendments aimed at preserving abortion access.

Those losses for anti-abortion Republicans and their wealthy backers have led the party to ramp up its attacks on the ballot initiative process itself in several states.

As The New York Timesreported Sunday, "The biggest and most immediate fight is in Ohio, where a coalition of abortion rights groups is collecting signatures to place a constitutional amendment on the ballot in November that would prohibit the state from banning abortion before a fetus becomes viable outside the womb, at about 24 weeks of pregnancy."

"Organizers were confident that the measure would reach the simple majority needed for passage, given polls showing that most Ohioans—like most Americans—support legalized abortion and disapprove of overturning Roe," the newspaper continued. "But Republicans in the state legislature are advancing a ballot amendment of their own that would raise the percentage of votes required to pass future such measures to a 60% supermajority. The measure has passed the Ohio Senate and is expected to pass the House this week."

The Republican initiative—which is backed by right-wing special interest groups such as the Buckeye Firearm Association, Ohio Right to Life, the Center for Christian Virtue, and the American Center for Law & Justice—would require just a simple-majority vote to pass, and it is expected to appear on the ballot in August.

The special election will mark a dizzying reversal for Ohio Republicans, who moved to effectively eliminate August elections last year due to their high costs and extremely low turnout.

"The side that wins is often the one that has a vested interest in the passage of the issue up for consideration," Frank LaRose, Ohio's Republican secretary of state and a supporter of the GOP attack on the ballot initiative process, wrote in testimony on August elections last year. "This isn't how democracy is supposed to work."

The GOP attack on direct democracy in Ohio, where abortion is heavily restricted, resembles efforts underway across the country. In January alone, Missouri Republicans introduced a dozen bills aimed at undercutting the ballot initiative process and weakening citizen lawmaking.

Democracy Docket noted that two of the Republican-authored resolutions in Missouri would, like the proposed amendment in Ohio, "raise the threshold to approve constitutional amendments to 60%."

According to the Ballot Initiative Strategy Center (BISC), at least 139 bills that would impact the ballot initiative process have been introduced in state legislatures this year.

"Efforts to undermine and weaken ballot measures have been increasing since the 2016 election in response to progressive wins and people-powered democracy at the ballot box," BISC said. "In many states, some politicians and wealthy special interests are trying to make it harder for voters to propose and pass ballot initiatives under the cover of so-called 'reforms.' These attacks have escalated and have become more nuanced, sophisticated, and would have deeper impacts on the initiative process."

While efforts to limit the ballot initiative process succeeded in some states last year, they failed elsewhere. As Common Dreamsreported, South Dakota voters overwhelmingly rejected a proposed constitutional amendment that would have raised the threshold for passage of most ballot measures from a simple majority to 60%.

In Michigan, Republican lawmakers attempted to have an abortion rights ballot initiative tossed even though organizers collected a record-shattering number of signatures from state residents. The GOP sabotage effort was blocked in court, and Michigan voters ultimately approved the proposition in November by a decisive margin.

But Republicans elsewhere are plowing ahead. The Times reported Sunday that "the North Dakota legislature this month approved a bill boosting the signature requirement for proposed constitutional amendments and requiring them to win approval in both primary and general elections."

"And in Arkansas, after voters last fall soundly rejected a constitutional amendment proposed by the legislature stiffening the requirements to get a measure on the ballot, the legislature simply passed new requirements as state law. Gov. Sarah Huckabee Sanders signed the law last month."

The Arkansas law more than tripled the number of counties where signatures must be collected for a citizen initiative to qualify for the ballot.

Randi Weingarten, president of the American Federation of Teachers, tweeted Sunday that Republicans are attacking the ballot initiative process because "they know that the American people will vote to ensure access to reproductive care."

As the Times reported, "Republicans in Ohio have said openly that their efforts to make ballot amendments harder to pass are aimed at blocking abortion rights. They are putting their measure on the ballot in August, typically a time of low turnout. It will not include the word 'abortion,' which abortion rights supporters say will make it hard to engage their voters."

The ACLU of Ohio warned that the Republican amendment would "enact minority rule" in the state.

"Republican lawmakers pushing these efforts want 41% of voters to block ballot initiatives that 59% of voters support," the group said. "This is not democracy."

GOP rep. echoes AOC’s call for Biden to 'ignore' Texas judge’s ruling on abortion pill

Rep. Nancy Mace (R-SC) on Monday echoed Rep. Alexandria Ocasio-Cortez (D-NY) in calling on the Biden Administration to “ignore” a federal judge’s ruling that suspended the Food and Drug Administration’s (FDA) 23-year-old approval of the abortion pill mifepristone.

Judge Matthew Kacsmaryk of the U.S. Northern District of Texas on Friday invalidated the FDA’s circa-2000 approval of mifepristone. The New York Times reports the judge’s preliminary injunction also invalidated “the FDA’s subsequent decisions that expanded the use of mifepristone in terminating early pregnancies.”

Speaking with CNN’s “State of the Union” on Sunday, Ocasio-Cortez called Kacsmaryk’s ruling “an extreme abuse of power” and “extraordinary example of judicial overreach.” The New York Democrat also said the ruling made “a mockery of our system, a mockery of our democracy and a mockery of our law.”

READ MORE: Even Ann Coulter admits that 'strict' GOP abortion bans are going too far

The executive branch has an enforcement discretion,” Ocasio-Cortez said.

As Axios reports, Mace on Tuesday told CNN she agrees the approval of mifepristone rests with the FDA.

“I support the usage of FDA-approved drugs even if we might disagree,” Mace said. “It’s not up to us to decide as legislators or even the court system”

READ MORE: Liberal victory in Wisconsin Supreme Court race is a 'five-alarm warning to Republicans': WSJ editorial board

“So I agree with ignoring [the ruling] at this point,” she added.

The U.S. Department of Justice on Monday appealed Kacsmaryk's "misguided" decision.

READ MORE:'Republicans may be in big trouble': The abortion issue keeps getting worse for GOP

'Despicable': Idaho becomes first US state to restrict interstate travel for abortion care

Idaho Gov. Brad Little on Wednesday made his state the first in the U.S. to restrict interstate travel for abortion care by signing legislation that aims to prevent minors from traveling to obtain an abortion without parental consent.

The Republican-authored law, H.B. 242, creates a new crime of "abortion trafficking" and establishes a minimum two-year prison sentence—and a maximum of five years—for anyone found guilty of committing it.

The law defines a perpetrator of "abortion trafficking" as "an adult who, with the intent to conceal an abortion from the parents or guardian of a pregnant, unemancipated minor, either procures an abortion... or obtains an abortion-inducing drug for the pregnant minor to use for an abortion by recruiting, harboring, or transporting the pregnant minor within this state commits the crime of abortion trafficking."

"It shall not be an affirmative defense to a prosecution... that the abortion provider or the abortion-inducing drug provider is located in another state," the measure's text states.

Little has said the law, which would empower Idaho's Republican attorney general to override local prosecutors if they refuse to enforce the restrictions, does not bar adults from traveling to obtain abortion care for themselves.

Current Idaho law bans nearly all abortions, meaning the new measure will, in practice, impact those traveling within Idaho to assist a pregnant minor in obtaining abortion medication from out of state and those crossing state lines to help a minor receive abortion care.

As HuffPost's Alanna Vagianos noted, the law "could apply to a grandmother driving a pregnant minor to the post office to pick up a package holding medication abortion or target an older brother driving a pregnant minor to a friend's house to self-manage an abortion at home."

With the draconian restrictions set to take effect in less than 30 days, abortion rights groups are vowing to fight as other states are likely to follow Idaho's lead. Last July, Senate Republicans blocked legislation that would have protected the right to travel for abortion nationwide.

Planned Parenthood Alliance Advocates West said Wednesday that "yet again, Idaho's governor disregarded constituents and signed H.B. 242 into law, creating the nation's first crime of so-called 'abortion trafficking,'"

"This legislation is despicable, and we're going to do everything in our power to stop it," the group added. "This bill criminalizes an adult assisting a young person accessing abortion care with the intent of concealing the abortion from their parent. While most young people include their parents in the decision to get an abortion, some are in dangerous, abusive situations."

"Idaho lawmakers have slipped under the radar with some of the strictest anti-abortion laws in the country," the group continued. "Now, they're using an incredibly serious term like trafficking to talk about young people traveling with trusted adults to access a legal procedure in another state."

Idaho healthcare providers and advocacy organizations, including Planned Parenthood and the ACLU, announced Wednesday that they are suing Idaho Attorney General Raúl Labrador over his claim in a recent legal opinion that Idaho law prohibits medical providers from "either referring a woman across state lines to access abortion services or prescribing abortion pills for the woman to pick up across state lines."

"Idaho law requires the suspension of a healthcare professional's license when he or she 'assists in performing or attempting to perform an abortion,'" Labrador wrote.

The advocacy coalition opposing that interpretation warned Wednesday that it "goes far beyond Idaho's law and is an extreme attempt to prevent healthcare providers from giving information to patients and to prevent Idahoans from accessing legal health care in another state."

"This is a five-alarm fire," said Rebecca Gibron, the CEO of Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky. "Banning abortion wasn't enough for anti-abortion extremists in Idaho; they now want to ban where you go, what information you're legally allowed to obtain, and even what health care providers can say."

"Attorney General Labrador’s opinion is an egregious extension of Idaho's abortion ban. We won't stand for it," Gibron added. "Everyone across the country should be paying attention to this extreme attempt at government overreach to control our movements in and out of the state, control free speech, and access to information. This opinion should worry you even if you don't live in Idaho.”

Ruling by Texas GOP judge could imperil millions of Americans

A Texas federal judge has voided Obamacare’s requirements that insurance companies cover the full costs of life-saving HIV prevention and treatment drugs, claiming requiring Christian employers to do so violates their rights under the federal Religious Freedom Restoration Act (RFRA).

In that same ruling on Thursday, U.S. District Judge Reed O’Connor, who has a lengthy history of deciding against LGBTQ people and in favor of the far Christian right, also voided requirements insurance companies, under the Affordable Care Act (ACA), cover other life-saving medications and procedures including cancer screenings, mental health services, and diabetes treatments, although for reasons unrelated to religion.

“In September,” Reuters reports, “O’Connor held that the US Preventive Services Task Force, which determines what qualifies as a covered preventive measure under the ACA, can’t validly do so because its members aren’t subject to Senate confirmation and their recommendations aren’t reviewed by constitutionally appointed government officials.”

Thursday’s decision is an extension of Judge O’Connor’s September ruling, in the same case, Braidwood Mgmt., Inc. v. Becerra.

Slate’s legal expert Mark Joseph Stern calls Judge O’Connor’s ruling “nothing short of catastrophic to the U.S. health care system.”

READ MORE: New Poll Sends Trump Damning Message About 2024 if He’s Criminally Indicted

“Millions of Americans, including many pregnant women, will have to forgo basic care if it is upheld,” he adds.

The case was brought by Dr. Steven Hotze, a far-right Republican activist and religious extremist who has attacked the LGBTQ community for decades. Last fall The New York Times identified Braidwood Management’s owner as “Dr. Steven F. Hotze, a well-known Republican donor and doctor from Houston, has previously challenged the Affordable Care Act on other grounds.”

The Times reports in that September ruling in this same case, Judge O’Connor wrote: “The PrEP mandate substantially burdens the religious exercise of Braidwood’s owners.” O’Connor, The Times added, wrote “that Dr. Hotze believes that covering PrEP drugs ‘facilitates and encourages homosexual behavior, intravenous drug use and sexual activity outside of marriage between one man and one woman.'”

HIV is not exclusive to people who engage in same-sex intimate relations, drug use, or sexual activity outside of marriage between one man and one woman.

In 2015, Dr. Hotze compared same-sex marriage to the Holocaust and gay people to murderers, defending his belief that Texas should ignore the impending Supreme Court ruling that found same-sex couples have a constitutional right to marriage.

Just two weeks ago Dr. Hotze was “kicked out of a state senate session,” The Daily Beast reported, “after he called transgender people ‘pedophiles.'”

“Major medical and patient groups,” Bloomberg Law reported on Thursday, “had argued that a nationwide order would jeopardize health care for millions of Americans, leading to preventable deaths and higher costs for treating diseases that could have been detected earlier by free screenings.”

READ MORE: Here’s How Five Republicans in Congress Are Responding to the Mass Shooting of 3 Children and 3 Adults in Nashville (Video)

According to Forbes, Judge O’Connor’s ruling on Thursday also voids required coverage for other “preventive services,” including “screenings for such cancers as breast cancer, colorectal cancer, cervical cancer and lung cancer, diabetes screenings, various screenings and interventions for pregnant people, statin use to prevent cardiovascular disease, vision screening for children and more.”

And yet, Judge O’Connor’s decision tossed “other arguments that tried to invalidate the contraceptive mandate in the ACA, so coverage for contraception will remain unaffected by Thursday’s ruling.”

The Biden Administration is expected to appeal, and according to Forbes because insurance policies are generally in effect for a calendar year, it’s unlikely any possible changes would be implemented before January.

Meanwhile, Judge O’Connor in 2019 overturned protections written into ObamaCare for transgender people, ruling they violate the religious rights of healthcare providers who hold religious beliefs that oppose the existence of transgender people.

Three years earlier, in 2016, O’Connor – who at that point already had a record of opposing LGBT rights – handed down a 38-page order in a lawsuit brought by Texas Attorney General Ken Paxton on behalf of 13 states, blocking the Obama administration from enforcing its guidance that said public schools should allow transgender students to use restroom and locker rooms based on their gender identity.

'A phenomenal disservice': OB/GYN blasts 'failure of the medical community to prioritize' menopausal women

When 2024 GOP presidential hopeful Nikki Haley proposed a mental fitness test for older politicians, her critics slammed the proposal as ageist. Many of those critics were Democrats, yet some Never Trump conservatives argued that Haley's messaging was terrible in light of the fact that many Republican voters are over 50.

Quite a few feminists have argued that as women age in the United States, they have to deal with ageism and sexism at the same time. That includes the way in which menopause is handled.

In an op-ed published by the Daily Beast on March 27, Dr. Mary Claire Haver (an OB-GYN) laments that women experiencing symptoms of menopause have often been treated dismissively in the medical community.

READ MORE:There's no such thing as law to police trans women that wouldn’t ultimately hurt all women

"The 'It's all in her head' medical mantra was very much alive and well," Haver explains. “If she was found to be postmenopausal, we would offer hormone replacement therapy (HRT) and send her on her way. If she was transitioning into menopause, well, we offered nothing."

The OB-GYN points out that in the United States, "one-third of the female population" is "peri- or postmenopausal." Yet many doctors, according to Haver, have done medicine a "phenomenal disservice" because of their "failure" to "prioritize…. menopausal women."

"A large part of this stems from the cultural guilt associated with growing, which holds that once women lose their fertility, they must be withered, washed-out, and unworthy," Haver observes. "Sadly, the negative societal perceptions of menopause and failure of the medical community to prioritize the health of this large group of individuals has resulted in a knowledge gap among women entering this phase of their lives, which could have a substantial negative influence on their overall quality of life."

Nonetheless, Haver describes some positive developments.

READ MORE:Nikki Haley's proposed 'mental competency test' panned as 'ageist' and 'absurd'

“Fortunately, there is hope on the horizon," the OB-GYN notes. "There has been an explosion over the past decade in the number of women telling their stories on social media and finding more sympathetic listeners, in the form of other women. Unwilling to accept the status quo and suffer in silence, this generation of menopausal women is sharing their journeys, names of helpful healthcare providers, as well as functional strategies for navigating this time in their lives…. Celebrities such as Naomi Watts, Angelina Jolie, Michelle Obama, and Salma Hayek are all openly discussing their own menopause journeys, thus helping to lift the secret, shame, and taboo surrounding this transitional time…. Change is coming in science, too. The North American Menopause Society is promoting groundbreaking menopause treatment research, offering training and certification in menopause care, and providing a helpful list of certified providers on its website."

READ MORE:How OB-GYNs are 'at the forefront' of the fight for abortion rights

Read The Daily Beast'sfull article at this link (subscription required).

Idaho Republicans want to keep doctors from treating ectopic pregnancies

“We demand rigidly defined areas of doubt and uncertainty!” exclaims a disgruntled philosopher in Douglas Adams’ Hitchhiker’s Guide to the Galaxy.

The philosophers had banded together to protest the advancement of computer science, which they believed was imposing entirely too much clarity on the existential mysteries that gave them job security.

The Idaho GOP and a coalition of antichoice groups in the state are taking a similar tack regarding the state’s murky and punitive abortion law.

This session, two Republican state legislators introduced a bill that would clarify key concepts in the state’s felony abortion ban. These include defining when an abortion is necessary to save the life of the pregnant person, and confirming once and for all that it’s not a felony to treat ectopic and nonviable pregnancies and to remove fetuses that have died.

It would also stop doctors who perform life-saving abortions from automatically being dragged before a judge to plead medical necessity as an affirmative defense.

Whatever happens with the felony abortion ban, Idaho doctors risk devastating lawsuits for treating one of the most common and dangerous gynecological emergencies: ectopic pregnancy.

Ectopic pregnancies are fertilized eggs that implant outside the uterus. These rogue ova will never become babies and they can kill the patient if they’re allowed to swell like a tumor on a speedrun.

It’s all about the uncertainty. A doctor doesn’t know if she’s going to get sued by a vengeful ex for treating an ectopic pregnancy, but it could happen. Uncertainty can be even more paralyzing than a clear-cut but draconian rule.

Rigidly defined areas of doubt and uncertainty can paralyze doctors while letting legislators off the hook for self-evidently stupid and unpopular policies, like forcing patients to wait in agonizing pain until their fallopian tubes rupture and their abdomens fill with blood. Or for letting bacteria rot their uteruses, and surge through their bodies, because their doomed fetus still has a heartbeat.

The Idaho Republican Party sent out an email Tuesday night claiming that the proposed changes were a ruse by doctors to “have more leeway to perform abortions in Idaho.” The head of the far-right Idaho Family Policy Center fretted in an email to supporters that a “special interest group” had drafted some of the language.

That group is the Idaho Medical Association, an utterly mainstream group that has been promoting medical excellence in the state since 1893. A hearing on the bill has been postponed amid the antichoice outcry.

The chilling effects of Idaho’s abortion laws are already being felt.

The only hospital serving a town of 9,000 people recently announced that it would no longer deliver babies in part because of the abortion ban. Families will soon have to drive 45 miles to deliver their babies. It was always a challenge to attract qualified doctors to small rural towns, but Idaho’s abortion politics are accelerating the brain drain. Doctors are fleeing the state because they don’t want to live in legal limbo. They don’t want to have to choose between satisfying their professional ethics and obeying the law. The law is so vague that it chills doctors who don’t even do abortions.

We’ve seen in state after state that exceptions to save the life of the pregnant person offer little practical protection. When a doctor might face a lengthy prison term, he or she will probably find an excuse to delay care, even when it endangers the life of a patient.

Even the antichoice movement is tiring of the charade. Instead of grappling with the ethical implications of denying life-saving care, national antichoice groups have started promulgating the absurd lie that abortion is never medically necessary.

In 2022, the Idaho Republicans voted nearly four to one to amend their party platform to criminalize all abortions, including lifesaving terminations. An exception for ectopic pregnancies was proposed and rejected.

When the goal is cruelty, uncertainty is a valuable commodity, and Idaho antichoicers have rallied to defend it.

This deadly fungus spread at an 'alarming rate' during the COVID-19 pandemic: CDC

In 2020 and 2021, the dominant health crisis in the United States and other countries was COVID-19 — a disease that, according to Johns Hopkins University in Baltimore, has killed more than 6.8 million people worldwide. That includes over 1.1 million fatalities in the U.S.

Although COVID-19 is still high contagious in March 2023, it isn’t as deadly as it was two or three years ago. Millions of people have been vaccinated, and most of 2023’s COVID-19 infections have not been fatal or required hospitalization.

According to the Centers for Disease Control and Prevention (CDC), the U.S. had another health crisis in 2021 — albeit one that didn’t receive as much attention as COVID-19. The CDC, on Monday, March 20, announced that a deadly fungus spread at an "alarming rate" during the pandemic.

READ MORE:How gonorrhea became more of a drug-resistant 'superbug' during the COVID-19 pandemic

New York Times reporter Matt Richtel, in an article published on March 20, explains, "The fungus, called Candida auris, preys primarily on older people with weakened immune systems and is particularly dangerous because it resists treatment by common antifungal medications. C. auris was first reported in the United States in 2016, showing up most notably in New York and Illinois, where public health officials hoped they could contain it by rigorous screening and infection control in long-term care facilities and nursing homes. But over the course of 2021, state and local health departments around the country reported 1474 clinical cases, about a 200 percent increase from the nearly 500 cases in 2019."

Candida auris, Richtel reports, is "now in half the 50 states, many with just a handful of cases, but with higher concentrations in California, Nevada, Texas and Florida." The journalist adds that according to CDC data, 2377 infections were reported in the U.S. in 2022.

Richtel observes, "It is likely that the coronavirus pandemic worsened the spread of C. auris, CDC officials said. With attention focused on COVID-19, less emphasis was put on screening for C. auris…. C. auris is not a particular threat to young healthy people, whose immune systems can fight it off, but can be transported on skin and clothing. Those who contract it can experience typical infection symptoms, like fever and chills that can intensify absent treatment. The fungus commonly strikes older patients, particularly those who have many visits or prolonged visits to health care facilities, where it can be hard to clean or eradicate."

READ MORE: 'A big fat target': Analysis explains how DeSantis could use the COVID-19 pandemic as a 2024 'secret weapon'

Read the New York Times' full report at this link (subscription required).


@2024 - AlterNet Media Inc. All Rights Reserved. - "Poynter" fonts provided by fontsempire.com.